Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Alcanza Clinical Research Acquires Innovation Medical Research Center | ||
| By: PR Newswire Association LLC. - 09 Apr 2024 | Back to overview list |
|
|
Investigator Site Network Continues to Expand Network Size and Patient Reach with Acquisition of Multi-Specialty Clinical Research Center ORLANDO, Fla., April 9, 2024 /PRNewswire/ -- Alcanza Clinical Research, a mission-focused investigator site network, has acquired Innovation Medical Research Center (Innovation), a multi-specialty clinical research center. This deal is a key part of Alcanza's growth strategy, marking the ninth acquisition since 2021, and enabling the site network to expand its therapeutic area capabilities and diversity of study participants.
Located in Palmetto Bay, Fla., Innovation conducts Phase I to Phase IV clinical trials in key therapeutic areas such as cardiology, dermatology, endocrinology, gastroenterology, infectious disease, internal medicine, nephrology, neurology, psychiatry, rheumatology, and women's health. "As Alcanza continues to expand, the addition of Innovation strengthens our capabilities in a variety of high-growth therapeutic areas," said Carlos Orantes, CEO, Alcanza. "Additionally, the center's prime location enables us to reach new, diverse patient populations, aligning with our mission to make clinical research accessible to everyone." "Joining an established site network, such as Alcanza, whose mission and values are closely aligned with ours, is vital to the continued growth and success of Innovation," said Omar Orama, Site Director. About Alcanza Clinical Research: Media Contact:
SOURCE Alcanza Clinical Research 
|
||
|
|
||
 | Back to overview list | |
View original content to download multimedia: